Nasasbiotech is a spin-off of a biomedical research project developed at the Translational Medical Oncology Laboratory of the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), which develops new clinical solutions to improve the diagnosis, prognosis, and treatment of cancer. Nasasbiotech‘s solutions are based on the needs of oncologists and follow an innovative and disruptive approach. They aim to reach clinical practice and overcome the main challenge in oncology today: the process of metastasis, responsible for 90% of cancer-related deaths. Our research focuses mainly on the study of circulating tumor cells or CTCs, their role in metastasis formation, their use as diagnostic and prognostic tools, and the development of systems for their control and capture. The company will soon start the process with regulatory authorities in order to bring a solution to clinics to help doctors fight different types of cancers, starting with ovarian cancer.
Business areas:
Medical oncology.
Business lines:
Public and private oncology hospitals.